EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?

Andreea Cristina Paraschiv, Vitalie Vacaras, Cristina Nistor, Cristiana Vacaras, Dorian Traian Nistor, Stefan Cristian Vesa, Silvina Ilut, Dafin F Muresanu

Journal of Gastrointestinal and Liver Diseases · 30.03.2024 · 33 (1) · 115-122

DOI: 10.15403/jgld-5241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 30.03.2024. Verfasst von Andreea Cristina Paraschiv und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.. . cristina.andre…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Probiotics, Autoimmune Diseases, Immunoglobulins. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of gut microbiota in autoimmune disorders like multiple sclerosis is gaining attention. Multiple sclerosis is characterized by inflammation, demyelination, and neurodegeneration in the central nervous system. Alterations in gut microbiota have been linked to multiple sclerosis development, with decreased beneficial bacteria and increased harmful species. The gut-brain axis is a complex interface influencing bidirectional interactions between the gut and the brain. Dysbiosis, an imbalance in gut microbiota, has been associated with autoimmune diseases. The influence of gut microbiota in multiple sclerosis is reversible, making it a potential therapeutic target. Probiotics, prebiotics, and fecal microbiota transplantation have shown promise in multiple sclerosis treatment, with positive effects on inflammation and immune regulation. Immunoglobulin Y (IgY) supplements derived from chicken egg yolk have potential as nutraceuticals or dietary supplements. IgY technology has been effective against various infections, and studies have highlighted its role in modulating gut microbiota and immune responses. Clinical trials using IgY supplements in multiple sclerosis are limited but have shown positive outcomes, including reduced symptoms, and altered immune responses. Future research directions involve understanding the mechanisms of IgY‘s interaction with gut microbiota, optimal dosage determination, and long-term safety assessments. Combining IgY therapy with other interventions and investigating correlations between microbiota changes and clinical outcomes are potential avenues for advancing multiple sclerosis treatment with IgY supplements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisProbioticsAutoimmune DiseasesImmunoglobulinsHumansDysbiosisDietary SupplementsInflammation

Substanzen

IgYImmunoglobulins

Autor:innen und Institutionen

  • Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.. . cristina.andreea.paraschiv@gmail.com.
  • Neurology Department, Cluj Emergency County Hospital, 400012 Cluj-Napoca, Romania; Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy. . vacaras.umfcluj@yahoo.com.
  • Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.. cristinapinzaru@yahoo.com.
  • Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania. cristianavacaras@gmail.com.
  • Department of Oncology and Radiotherapy, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. nistor.dorian@yahoo.com.
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, Iuliu Haţieganu University of Medicine and Pharmacy, 400349 Cluj Napoca, Romania.. stefanvesa@gmail.com.

Zitieren

APA

Paraschiv, A. C., Vacaras, V., Nistor, C., Vacaras, C., Nistor, D. T., Vesa, S. C., Ilut, S., & Muresanu, D. F. (2024). Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?. Journal of Gastrointestinal and Liver Diseases, 33(1), 115-122. https://doi.org/10.15403/jgld-5241

Vancouver

Paraschiv AC, Vacaras V, Nistor C, Vacaras C, Nistor DT, Vesa SC, et al. Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?. Journal of Gastrointestinal and Liver Diseases. 2024;33(1):115-122. doi:10.15403/jgld-5241

BibTeX
@article{Paraschiv2024,
  author = {Paraschiv, Andreea Cristina and Vacaras, Vitalie and Nistor, Cristina and Vacaras, Cristiana and Nistor, Dorian Traian and Vesa, Stefan Cristian and Ilut, Silvina and Muresanu, Dafin F},
  title = {Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2024},
  volume = {33},
  number = {1},
  pages = {115--122},
  doi = {10.15403/jgld-5241}
}
Kostenlos starten →